Trial intelligence / Profile preview

Anakinra vs DMARDs in Refractory Adult-onset Still's Disease

NCT01033656Phase 2Completed

Sponsor
University of Helsinki
Start
Dec 2005
Primary completion
Mar 2010
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 2 trial of anakinra in adult-onset Still's disease (AOSD), sponsored by University of Helsinki. Started Dec 2005; status: completed.

02

Drugs

anakinra
03

Conditions

adult-onset Still's disease (AOSD)

Beyond the preview

Go deeper on NCT01033656.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01033656.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call